In PBMCs (peripheral blood mononuclear cells) of patients with AD and aMCI (amnestic mild cognitive impairment), the typical inflammasomes NLRP3/caspase-1/GSDMD signaling pathway-mediated pyroptosis is activated. This evidence concerns the gene NLRP3 and Alzheimer disease.